Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Yuan J, Ku GY, Gallardo HF, Orlandi F, Manukian G, Rasalan TS, Xu Y, Li H, Vyas S, Mu Z, Chapman PB, Krown SE, Panageas K, Terzulli SL, Old LJ, Houghton AN, Wolchok JD.
Yuan J, et al. Among authors: houghton an.
Cancer Immun. 2009 Jun 5;9:5.
Cancer Immun. 2009.
PMID: 19496531
Free PMC article.
Clinical Trial.